NCT00047502 2018-11-07Study of Lonafarnib and Gleevec in Chronic Myelogenous LeukemiaM.D. Anderson Cancer CenterPhase 1 Completed23 enrolled
NCT00038597 2018-10-30Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)M.D. Anderson Cancer CenterPhase 2 Completed13 enrolled